GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/The Boškoski–Costamagna ERCP Trainer

The Boškoski–Costamagna ERCP Trainer

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated May 1, 2025

Quick Answer

The Boškoski–Costamagna ERCP Trainer is an advanced simulation tool designed to aid novice trainees in developing their skills in Endoscopic Retrograde Cholangiopancreatography (ERCP), a complex endoscopic procedure used to diagnose and treat conditions affecting the bile ducts, pancreatic ducts, and gallbladder. This trainer provides a structured and controlled environment for hands-on practice, allowing learners to gain technical proficiency before performing procedures on actual patients.


The Boškoski–Costamagna ERCP Trainer is an advanced simulation tool designed to aid novice trainees in developing their skills in Endoscopic Retrograde Cholangiopancreatography (ERCP), a complex endoscopic procedure used to diagnose and treat conditions affecting the bile ducts, pancreatic ducts, and gallbladder. This trainer provides a structured and controlled environment for hands-on practice, allowing learners to gain technical proficiency before performing procedures on actual patients.

The use of the Boškoski–Costamagna ERCP Trainer offers significant advantages in the training pathway for ERCP. By incorporating simulation-based training early in the learning process, trainees can achieve enhanced outcomes, including:

1. **Improved Biliary Cannulation Success**: Practicing on the simulator allows trainees to refine their techniques for accessing the bile duct, a critical and challenging component of ERCP.

2. **Faster Procedure Times**: Simulation training helps users develop efficiency in performing ERCP, translating into reduced procedure times in real clinical settings.

3. **Accelerated Skill Development**: The hands-on experience provided by the trainer facilitates quicker mastery of essential ERCP skills, enabling trainees to progress toward competence more rapidly.

The integration of the Boškoski–Costamagna ERCP Trainer into ERCP education programs is supported by evidence that it enhances trainee performance. By simulating real-life scenarios, it allows learners to practice and refine their skills repeatedly without risk to patients. This structured training approach not only boosts confidence but also has the potential to shorten the time required for trainees to become proficient in ERCP procedures.

In summary, the Boškoski–Costamagna ERCP Trainer is a critical innovation in medical education, offering a safe, effective, and efficient way to prepare novice endoscopists for the challenges of ERCP. Its adoption in training programs can lead to better patient outcomes and improved procedural success rates.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer